FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045712842> ?p ?o ?g. }

• W2045712842 endingPage "402" @default.
• W2045712842 startingPage "393" @default.
• W2045712842 abstract "Aim: To design, manufacture and test a second generation leptin receptor (ObR) agonist glycopeptide derivative. The major drawback to current experimental therapies involving leptin protein is the appearance of treatment resistance. Our novel peptidomimetic was tested for efficacy and lack of resistance induction in rodent models of obesity and appetite reduction. Methods: The glycopeptide containing two additional non-proteinogenic amino acids was synthesized by standard solid-phase methods. Normal mice were fed with peanuts until their blood laboratory data and liver histology showed typical signs of obesity but not diabetes. The mice were treated with the peptidomimetic at 0.02, 0.1 or 0.5 mg/kg/day intraperitoneally side-by-side with 0.1 mg/kg/day leptin for 11 days. After termination of the assay, the blood cholesterol and glucose amounts were measured, the liver fat content was visualized and quantified and the remaining mice returned to normal diet and were allowed to mate. In parallel experiments normal rats were treated intranasally with the glycopeptide at 0.1 mg/kg/day for 10 days. Results: The 12-residue glycosylated leptin-based peptidomimetic E1/6-amino-hexanoic acid (Aca) was designed to target a principal leptin/ObR-binding interface. E1/Aca induced leptin effects in ObR-positive cell lines at picomolar concentrations and readily crossed the blood-brain barrier (BBB) following intraperitoneal administration. The peptide initiated typical leptin-dependent signal transduction pathways both in the presence and absence of leptin protein. The peptide also reduced weight gain in mice fed with high-fat peanut diet in a dose-dependent manner. Obese mice receiving peptide E1/Aca at a 0.5 mg/kg/day dose lost weight, corresponding to a net 6.5% total body weight loss, while similar mice treated with leptin protein did not. Upon cessation of the weight loss treatment, several obesity-related pathologies (i.e. abnormal metabolic profile and liver histology as well as infertility) normalized in peptide-, but not leptin-treated, mice. Peptide E1/Aca added intranasally to growing normal rats decelerated normal weight gain corresponding to a net 6.8% net total body weight loss with statistical significance. Conclusions: No resistance induction to peptide E1/Aca or toxicity in either obese or healthy rodents was observed, indicating the potential for widespread utility of the peptidomimetic in the treatment of leptin-deficiency disorders. We provide additional proof for the hypothesis that difficulties in current leptin therapies reside at the BBB penetration stage, and we document that by either glycosylation or intranasal peptide administration we can overcome this limitation." @default.
• W2045712842 created "2016-06-24" @default.
• W2045712842 creator A5005162238 @default.
• W2045712842 creator A5012112191 @default.
• W2045712842 creator A5024008411 @default.
• W2045712842 creator A5039646916 @default.
• W2045712842 creator A5040431386 @default.
• W2045712842 creator A5049740628 @default.
• W2045712842 creator A5051625056 @default.
• W2045712842 creator A5051860064 @default.
• W2045712842 creator A5053145771 @default.
• W2045712842 creator A5068311676 @default.
• W2045712842 date "2010-03-30" @default.
• W2045712842 modified "2023-09-26" @default.
• W2045712842 title "Leptin-based glycopeptide induces weight loss and simultaneously restores fertility in animal models" @default.
• W2045712842 cites W1492605893 @default.
• W2045712842 cites W1554123323 @default.
• W2045712842 cites W1839359298 @default.
• W2045712842 cites W1967135896 @default.
• W2045712842 cites W1970666401 @default.
• W2045712842 cites W1974760551 @default.
• W2045712842 cites W1979340145 @default.
• W2045712842 cites W1980386342 @default.
• W2045712842 cites W1990282064 @default.
• W2045712842 cites W1994397451 @default.
• W2045712842 cites W1995277768 @default.
• W2045712842 cites W1996713062 @default.
• W2045712842 cites W1996894160 @default.
• W2045712842 cites W1997157145 @default.
• W2045712842 cites W2004597995 @default.
• W2045712842 cites W2005568660 @default.
• W2045712842 cites W2022443359 @default.
• W2045712842 cites W2022726845 @default.
• W2045712842 cites W2033602783 @default.
• W2045712842 cites W2034418213 @default.
• W2045712842 cites W2042535492 @default.
• W2045712842 cites W2042820130 @default.
• W2045712842 cites W2043458888 @default.
• W2045712842 cites W2057223343 @default.
• W2045712842 cites W2060682066 @default.
• W2045712842 cites W2061824972 @default.
• W2045712842 cites W2063088646 @default.
• W2045712842 cites W2075082469 @default.
• W2045712842 cites W2084434253 @default.
• W2045712842 cites W2086139024 @default.
• W2045712842 cites W2101746873 @default.
• W2045712842 cites W2102214369 @default.
• W2045712842 cites W2126446779 @default.
• W2045712842 cites W2132605558 @default.
• W2045712842 cites W2136902089 @default.
• W2045712842 cites W2137210176 @default.
• W2045712842 cites W2138339809 @default.
• W2045712842 cites W2147788805 @default.
• W2045712842 cites W2151484864 @default.
• W2045712842 cites W2154821368 @default.
• W2045712842 cites W2156218782 @default.
• W2045712842 cites W2157540558 @default.
• W2045712842 cites W2158129157 @default.
• W2045712842 cites W2162565031 @default.
• W2045712842 doi "https://doi.org/10.1111/j.1463-1326.2009.01170.x" @default.
• W2045712842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20415687" @default.
• W2045712842 hasPublicationYear "2010" @default.
• W2045712842 type Work @default.
• W2045712842 sameAs 2045712842 @default.
• W2045712842 citedByCount "29" @default.
• W2045712842 countsByYear W20457128422012 @default.
• W2045712842 countsByYear W20457128422013 @default.
• W2045712842 countsByYear W20457128422014 @default.
• W2045712842 countsByYear W20457128422015 @default.
• W2045712842 countsByYear W20457128422017 @default.
• W2045712842 countsByYear W20457128422019 @default.
• W2045712842 countsByYear W20457128422020 @default.
• W2045712842 countsByYear W20457128422021 @default.
• W2045712842 countsByYear W20457128422022 @default.
• W2045712842 countsByYear W20457128422023 @default.
• W2045712842 crossrefType "journal-article" @default.
• W2045712842 hasAuthorship W2045712842A5005162238 @default.
• W2045712842 hasAuthorship W2045712842A5012112191 @default.
• W2045712842 hasAuthorship W2045712842A5024008411 @default.
• W2045712842 hasAuthorship W2045712842A5039646916 @default.
• W2045712842 hasAuthorship W2045712842A5040431386 @default.
• W2045712842 hasAuthorship W2045712842A5049740628 @default.
• W2045712842 hasAuthorship W2045712842A5051625056 @default.
• W2045712842 hasAuthorship W2045712842A5051860064 @default.
• W2045712842 hasAuthorship W2045712842A5053145771 @default.
• W2045712842 hasAuthorship W2045712842A5068311676 @default.
• W2045712842 hasConcept C124790011 @default.
• W2045712842 hasConcept C126322002 @default.
• W2045712842 hasConcept C134018914 @default.
• W2045712842 hasConcept C137610392 @default.
• W2045712842 hasConcept C185592680 @default.
• W2045712842 hasConcept C2777391703 @default.
• W2045712842 hasConcept C2779281246 @default.
• W2045712842 hasConcept C2779306644 @default.
• W2045712842 hasConcept C2780613262 @default.
• W2045712842 hasConcept C501593827 @default.
• W2045712842 hasConcept C511355011 @default.
• W2045712842 hasConcept C515207424 @default.

• next